U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07725705) titled 'SHR2554 Plus Liposomal Mitoxantrone as First-line Treatment for Peripheral T-cell Lymphoma (PTCL)' on July 21.
Brief Summary: This is a single-arm, multicenter, Phase Ib/IIa study designed to explore the efficacy and safety of SHR2554 in combination with liposomal mitoxantrone for the treatment of patients with treatment-naive peripheral T-cell lymphoma (PTCL). The study is divided into a Phase Ib safety lead-in phase and a Phase IIa dose expansion phase.
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
PTCL
First Line Treatment
Intervention:
DRUG: SHR2554 combined with Liposomal Mitoxantrone
Patients will rece...